Performance Comparison of Two Monthly Replacement Silicone Hydrogel Multifocal Lens Types

NCT ID: NCT06232590

Last Updated: 2025-02-12

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-23

Study Completion Date

2024-07-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate and compare the performance of two monthly replacement multifocal contact lenses in existing wearers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This was a prospective, randomized, participant-masked, crossover, bilateral dispensing study. Each lens type was worn for approximately 4-6 weeks: the lens prescription of each lens type was optimized after 3-10 days wearing experience, prior to starting a 1-month (28-32 days) wear period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Presbyopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Lens, then Test Lens

Participants wore Control Lens for 1 month, then the Test Lens for 1 month

Group Type EXPERIMENTAL

Control Lens (comfilcon A)

Intervention Type DEVICE

Multifocal monthly replacement contact lens for 1 month

Test Lens (lehfilcon A)

Intervention Type DEVICE

Multifocal monthly replacement contact lens for 1 month

Test Lens, then Control Lens

Participants wore the Test Lens for 1 month, then the Control Lens for 1 month

Group Type EXPERIMENTAL

Control Lens (comfilcon A)

Intervention Type DEVICE

Multifocal monthly replacement contact lens for 1 month

Test Lens (lehfilcon A)

Intervention Type DEVICE

Multifocal monthly replacement contact lens for 1 month

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Control Lens (comfilcon A)

Multifocal monthly replacement contact lens for 1 month

Intervention Type DEVICE

Test Lens (lehfilcon A)

Multifocal monthly replacement contact lens for 1 month

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Were at least 42 years of age and had full legal capacity to volunteer;
2. Had read and signed an information consent letter;
3. Self-reported having had a full eye examination in the previous two years;
4. Anticipated being able to wear the study lenses for at least 8 hours a day, 5 days a week;
5. Were willing and able to follow instructions and maintain the appointment schedule;
6. Habitually wore spherical multifocal soft contact lenses, for the past 3 months minimum:

* Maximum of 4 participants (out of 12) per site could be habitual wearers of daily disposable lenses,
* Maximum of 4 participants (out of 12) per site could be habitual wearers of Biofinity Multifocal,
* Maximum of 4 participants (out of 12) per site could be habitual wearers of either TOTAL30 Multifocal or AirOptix plus HydraGlyde Multifocal
7. Had refractive astigmatism no higher than -0.75DC;
8. Is presbyopic and requires a reading addition of at least +0.75D and no more than +2.50D;
9. Could be fit and achieve binocular distance vision of at least 20/30 Snellen which participants also deem to be 'acceptable', with the available study lens parameters (Distance sphere +4 to -6; near addition as per study design).

Exclusion Criteria

1. Were participating in any concurrent clinical or research study;
2. Had any known active ocular disease and/or infection that contraindicated contact lens wear;
3. Had a systemic or ocular condition that in the opinion of the investigator may have affected a study outcome variable;
4. Were using any systemic or topical medications that in the opinion of the investigator may have affect contact lens wear or a study outcome variable;
5. Had known sensitivity to the diagnostic sodium fluorescein used in the study;
6. Self-reported as pregnant, lactating or planning a pregnancy at the time of enrolment;
7. Had undergone refractive error surgery or intraocular surgery.
Minimum Eligible Age

42 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre for Ocular Research & Education, Canada

OTHER

Sponsor Role collaborator

CooperVision International Limited (CVIL)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andrew Sacco

Role: PRINCIPAL_INVESTIGATOR

Sacco Eye Group

David Wilkinson

Role: PRINCIPAL_INVESTIGATOR

Spadina Optometry

Katherine Bickle

Role: PRINCIPAL_INVESTIGATOR

ProCare Vision Center

Dustin Gardner

Role: PRINCIPAL_INVESTIGATOR

New Bremen EyeCare

Gina Wesley

Role: PRINCIPAL_INVESTIGATOR

Complete Eye Care of Medina

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Complete Eye Care of Medina

Medina, Minnesota, United States

Site Status

Sacco Eye Group

Vestal, New York, United States

Site Status

ProCare Vision Center

Granville, Ohio, United States

Site Status

New Bremen EyeCare

New Bremen, Ohio, United States

Site Status

Spadina Optometry

Toronto, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EX-MKTG-153

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.